Answers are grounded in this paper and cite their sources.
LUPUS ERYTHEMATOSUS (LE) is an autoimmune connective tissue disease with a wide range of skin (cutaneous lupus erythematosus [CLE]) and/or systemic (systemic lupus erythematosus [SLE]) manifestations.Cutaneous involvement is found in up to 80% of patients with SLE,1 and CLE is observed as an initial manifestation of SLE in 0-42% of cases.2LE skin changes are divided into LEspecific (acute CLE, subacute CLE, chronic CLE) and LE-nonspecific (vascular and nonvascular signs) subtypes.3Some of these are more likely to lead to scarring (chronic CLE), but others have a higher risk of progression to SLE (acute CLE, subacute CLE).4
No takes yet. Share an insight, caveat, or question.
Guleva (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: